title: Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo.
abstract: Protein kinase C (PKC) modulates cardiomyocyte function by phosphorylation of intracellular targets including myofilament proteins. Data generated from studies on in vitro heart preparations indicate that PKC phosphorylation of troponin I (TnI), primarily via PKC-epsilon, may slow the rates of cardiac contraction and relaxation (+dP/dt and -dP/dt). To explore this issue in vivo, we employed transgenic mice [mutant TnI (mTnI) mice] in which the major PKC phosphorylation sites on cardiac TnI were mutated by alanine substitutions for Ser(43) and Ser(45) and studied in situ hemodynamics at baseline and increased inotropy. Hearts from mTnI mice exhibited increased contractility, as shown by a 30% greater +dP/dt and 18% greater -dP/dt than FVB hearts, and had a negligible response to isoproterenol compared with FVB mice, in which +dP/dt increased by 33% and -dP/dt increased by 26%. Treatment with phenylephrine and propranolol gave a similar result; FVB mouse hearts demonstrated a 20% increase in developed pressure, whereas mTnI mice showed no response. Back phosphorylation of TnI from mTnI hearts demonstrated that the mutation of the PKC sites was associated with an enhanced PKA-dependent phosphorylation independent of a change in basal cAMP levels. Our results demonstrate the important role that PKC-dependent phosphorylation of TnI has on the modulation of cardiac function under basal as well as augmented states and indicate interdependence of the phosphorylation sites of TnI in hearts beating in situ.
authors.affiliation: Section of Cardiology, University of Illinois, 840 S. Wood Street (M/C 715), Chicago, IL 60612, USA. broman@uic.edu
authors.forename: Brian B
authors.initials: BB
authors.lastname: Roman
authors.forename: Paul H
authors.initials: PH
authors.lastname: Goldspink
authors.forename: Elyse
authors.initials: E
authors.lastname: Spaite
authors.forename: Dalia
authors.initials: D
authors.lastname: Urboniene
authors.forename: Ron
authors.initials: R
authors.lastname: McKinney
authors.forename: David L
authors.initials: DL
authors.lastname: Geenen
authors.forename: R John
authors.initials: RJ
authors.lastname: Solaro
authors.forename: Peter M
authors.initials: PM
authors.lastname: Buttrick
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D006332:Cardiomegaly / Q000378:metabolism / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000494:pharmacology; D003326:Coronary Circulation / Q000502:physiology; D000242:Cyclic AMP / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D004452:Echocardiography; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D016296:Mutagenesis / Q000502:physiology; D009200:Myocardial Contraction / Q000502:physiology*; D010766:Phosphorylation; D011493:Protein Kinase C / Q000378:metabolism*; D051744:Protein Kinase C-epsilon; D019210:Troponin I / Q000235:genetics* / Q000378:metabolism*
chemical_list: D002316:Cardiotonic Agents; D019210:Troponin I; D000242:Cyclic AMP; C497256:Prkce protein, mouse; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C; D051744:Protein Kinase C-epsilon; D007545:Isoproterenol; D002118:Calcium